<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04073654</url>
  </required_header>
  <id_info>
    <org_study_id>SOI_1_RCT_MT</org_study_id>
    <nct_id>NCT04073654</nct_id>
  </id_info>
  <brief_title>SA Versus SOI Surfaces for Single Implant-supported Crown</brief_title>
  <official_title>Clinical Evaluation and Primary Stability of Early Loaded Implants With Sandblasted and Acid-etched Surface Versus Implants With SA Surface Modified With pH Buffering Agent: a Multicenter Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Osstem AIC</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Osstem AIC</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this randomized controlled trial is to compare clinical data and implant
      stability of immediately loaded TSIII Osstem implants with Sandblasted and Acid-etched (SA)
      surface versus implants with SA surface modified with pH buffering agent for the
      rehabilitation of single implant-supported crown.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study aimed to evaluate if there are some benefits using novel implant surface. This
      surface should improve the secondary implant stability, reducing the overall time needed for
      the osseointegration. main benefits in clinical practice should be reduced treatment time.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 26, 2019</start_date>
  <completion_date type="Anticipated">October 15, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized controlled trial, split-mouth design</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
    <masking_description>Implants have same macro design.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Implant failure</measure>
    <time_frame>From implant placement up to 60 months after loading</time_frame>
    <description>Implant removal for any reason will be considered an implant failure.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Crown failure</measure>
    <time_frame>From crown delivery up to 60 months</time_frame>
    <description>Crown replacement for any reason will be considered a crown failure.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Complications</measure>
    <time_frame>From implant placement up to 60 months after loading</time_frame>
    <description>Any complications will be recorded. Examples of biological complications are: nerve injury, fistula, peri-implantitis. Examples of biomechanical complications are fracture of the abutments screw, loosening of the crown, fracture of the ceramic.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Peri-implant marginal bone level (MBL) changes</measure>
    <time_frame>From implant placement up to 60 months after loading</time_frame>
    <description>It will be assessed on periapical radiographs taken with the paralleling technique. The distance between marginal bone level and implant/abutment junction, will be measured at both mesial and distal sides and averaged. Bone level changes at single implants will be averaged at group level. Non-digital radiographs will be scanned, digitized, and stored in a personal computer. Peri-implant marginal bone levels will be measured using the Scion Image (Scion Corporation, Frederick, MD, USA) software. The software will be calibrated for every single image using the known distance of the implant neck. Measurements of the mesial and distal bone crest level adjacent to each implant will be made to the nearest 0.01 mm. Reference points for the linear measurements will be: the coronal margin of the implant collar and the most coronal point of bone-to-implant contact.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Probing pocket depth (PPD)</measure>
    <time_frame>From crown delivery up to 60 months</time_frame>
    <description>Probing pocket depth will be measured by a blinded operator, with a periodontal probe (PCP-UNC 15, Hu-Friedy Manufacturing, Chicago, IL, USA). Three vestibular and three lingual values will be collected and averaged for each implant.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bleeding on probing (BOP)</measure>
    <time_frame>From crown delivery up to 60 months</time_frame>
    <description>Bleeding on probing will be measured by a blinded operator, with a periodontal probe (PCP-UNC 15, Hu-Friedy Manufacturing, Chicago, IL, USA). Three vestibular and three lingual values will be collected and averaged for each implant.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>plaque index (PI)</measure>
    <time_frame>From implant placement up to 60 months after loading</time_frame>
    <description>Plaque index will be measured by a blinded operator, with a periodontal probe (PCP-UNC 15, Hu-Friedy Manufacturing, Chicago, IL, USA) at delivery of the definitive crowns, 1, 3, and 5 years follow-up in function. Three vestibular and three lingual values will be collected for each implant.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Implant stability quotient</measure>
    <time_frame>The ISQ values will be recorded at the time of implant placement (baseline) and then 1,2,3,4,5,6,7,8, and 12 weeks after implant placement.</time_frame>
    <description>The implant stability quotient will be recorded by the blind outcome assessor using resonance frequency analysis (Osstell Mentor; Osstell, Goteborg, Sweden).7 Buccopalatal and mesiodistal measurements will be taken and averaged, with the result being displayed by the device in ISQ units, ranging from 1 to 100.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pink Esthetic Score</measure>
    <time_frame>From crown delivery up to 60 months</time_frame>
    <description>The aesthetic evaluation will be performed according to the pink aesthetic score on the vestibular and occlusal pictures taken including at least one adjacent tooth per side.8 The values will be assessed at definitive prosthesis delivery, and then early up to the end of the follow-up. Seven variables (mesial papilla, distal papilla, soft-tissue level, soft-tissue contour, alveolar process deficiency, soft-tissue color and texture) will be assessed with a 2-1-0 score (2 being best and 0 being poorest) by the same blinded dentist.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Dental Implant Failed</condition>
  <condition>Bone Resorption</condition>
  <arm_group>
    <arm_group_label>SA Implants</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Dental implant with sandblasted and Acid-etched (SA) surface</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SOI Implants</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Same dental implant with sandblasted and Acid-etched surface modified with pH buffering agent</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Placement of dental implants (surgical procedure)</intervention_name>
    <description>The two study implants have to be placed in the same surgical session according to similar procedures. Implants will be placed in the planned anatomic sites by using a flapless or a miniflap approach. Implants sites will be prepared based on the bone density, and according to the manufacturers's instruction by using the 122 Taper kit (Osstem Implant).</description>
    <arm_group_label>SA Implants</arm_group_label>
    <arm_group_label>SOI Implants</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Any partially edentulous subject requiring at least two single (preferable
             non-adjacent) implant-supported crowns, being at least 18 year old and able to sign an
             informed consent will be screened for eligibility. Bone volumes should allow the
             placement of two implants at least 8.5 mm (maximum 10 mm) long and 4.5 mm (minimum 3.5
             mm) wide, with a minimal insertion torque of 30 Ncm. Implants can be placed in
             previous post-extractive socket or in augmented bone, if at least 4 to 6 months have
             passed from the extraction or from augmentation procedures.

        Exclusion Criteria:

          -  Patients unable to commit to 5 years follow-up.

          -  General contraindications to implant surgery.

          -  Less then 4 mm of keratinised gingiva crestally (at the implant sites).

          -  Immune-suppressed/compromised patients.

          -  Patients irradiated in the head and/or neck.

          -  Uncontrolled diabetes.

          -  Pregnancy or lactation.

          -  Untreated periodontal disease.

          -  Poor oral hygiene and motivation (full mouth bleeding and full mouth plaque index
             higher than 25%).

          -  Addiction to alcohol or drugs.

          -  Psychiatric problems and/or unrealistic expectations.

          -  Patients with an acute infection or suppuration in the site intended for implant
             placement.

          -  Patients needing any form of tissue augmentation at implant placement.

          -  Immediate post-extractive implants (implants can be placed after a 3-month healing
             period).

          -  Patients treated or under treatment with intravenous amino-bisphosphonates.

          -  Patients referred only for implant placement if the follow-up cannot be done at the
             treatment center.

          -  Patients participating in other studies, if the present protocol could not be fully
             adhered to.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Marco Tallarico</last_name>
    <phone>+3280758769</phone>
    <email>me@studiomarcotallarico.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>Erta Xhanari</name>
      <address>
        <city>Tirana</city>
        <country>Albania</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erta Xhanari</last_name>
      <email>info@ertaxhanari.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Elitsa Deliverska</name>
      <address>
        <city>Sofia</city>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elitsa Deliverska</last_name>
      <email>elitsadeliverska@yahoo.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Fulvio Gatti</name>
      <address>
        <city>Milan</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fulvio Gatti, Dr</last_name>
      <phone>+39 ‭339 6441920‬</phone>
      <email>fudy@libero.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Studio Odontoiatrico Marco Tallarico</name>
      <address>
        <city>Rome</city>
        <zip>00151</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marco Tallarico, Dr</last_name>
      <phone>+39 066630646</phone>
      <email>me@studiomarcotallarico.it</email>
    </contact>
    <investigator>
      <last_name>Marco Tallarico, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Leonardo Muzzi</name>
      <address>
        <city>Siena</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Leonardo Muzzi</last_name>
      <email>leo@leomuzzi.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Łukasz Zadrożny</name>
      <address>
        <city>Warsaw</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Łukasz Zadrożny</last_name>
      <email>lukasz.zadrozny@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cesaltino Remedios</name>
      <address>
        <city>Fatima</city>
        <country>Portugal</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cesaltino Remedios</last_name>
      <email>cesaltinoremedios@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mircea</name>
      <address>
        <city>Craiova</city>
        <country>Romania</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mircea Gheorghita</last_name>
      <email>gheorghitamircea@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Andre de Waal</name>
      <address>
        <city>South Africa</city>
        <country>South Africa</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andre de Waal</last_name>
      <email>andre@adewaal.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Nicolas Widmer</name>
      <address>
        <city>Bern</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicolas Widmer</last_name>
      <email>nicolas.widmer@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Albania</country>
    <country>Bulgaria</country>
    <country>Italy</country>
    <country>Poland</country>
    <country>Portugal</country>
    <country>Romania</country>
    <country>South Africa</country>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>June 27, 2019</study_first_submitted>
  <study_first_submitted_qc>August 27, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 29, 2019</study_first_posted>
  <last_update_submitted>September 29, 2019</last_update_submitted>
  <last_update_submitted_qc>September 29, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 1, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Osstem AIC</investigator_affiliation>
    <investigator_full_name>Marco Tallarico</investigator_full_name>
    <investigator_title>Coordinator</investigator_title>
  </responsible_party>
  <keyword>Dental implants</keyword>
  <keyword>Implant surfaces</keyword>
  <keyword>Marginal bone loss</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bone Resorption</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

